In order to test our hypothesis, we selected the TAC model and cultured mycardial fibroblast that were treated with angiotensin (ANG-II) and tissue growth factor-β (TGF-β), respectively, to elucidate the potential effects of serpinE2 on cardiac fibrosis and related cell signaling. Here, SERPINE2 is linked to persistent truncus arteriosus.